Tum- comprises a class of genes, mutation of which in P815 tumor cells has led to the acquisition of new cytotoxic T cell-recognized epitopes. The cells carrying the mutant alleles have impaired tumorigenicity compared with their progenitors due to in vivo induction of a cytotoxic T-cell response specific for tum- antigens. Two tum- genes, P91A and P35B, were found to be single copy loci mapping to chromosomes 11 and 15 respectively. A third, P198, was found to map to chromosome 7 and to be a member of a small gene family with other members on chromosomes 13, 14, and 15. Multiple P198-related sequences were found in other mammalian species suggesting the P198 related gene family is a general feature of mammalian genomes
The P91A tumour minus (tum-) antigen is a tumour specific transplantation antigen expressed on the P...
T cells that recognize self antigen are clonally deleted in the thymus--a maturation process that oc...
Tumour development is a complex process involving susceptibility loci (oncogenes) and the accumulati...
Mutagen treatment of P815 tumour cells produces tum- variants that are rejected by syngeneic mice be...
Mutagen treatment of P815 tumour cells produces tum- variants that are rejected by syngeneic mice be...
Mutagen treatment of mouse P815 tumor cells produces immunogenic mutants that express new transplant...
Immunogenic tumor cell variant P35 was obtained by mutagen treatment of mouse mastocytoma P815. It e...
On the basis of the results reviewed here, there are two major mechanisms whereby tumour rejection a...
Mouse mastocytoma P815 expresses several distinct tumor rejection antigens recognized by syngeneic c...
Mouse mastocytoma P815 expresses several distinct tumor rejection antigens recognized by syngeneic c...
Tumor-associated transplantation antigens (TATA) are commonly found on rodent tumors induced by onco...
Male transmission ratio distortion (TRD) is a property of mouse t haplotypes requiring the t complex...
Transplantation experiments have demonstrated that most mouse tumors express antigens that can const...
AbstractDespite thousands of genetic polymorphisms among MHC matched mouse strains, a few unknown hi...
Minor histocompatibility (H) loci encode alloantigens that are recognized by cytotoxic T (Tc) lympho...
The P91A tumour minus (tum-) antigen is a tumour specific transplantation antigen expressed on the P...
T cells that recognize self antigen are clonally deleted in the thymus--a maturation process that oc...
Tumour development is a complex process involving susceptibility loci (oncogenes) and the accumulati...
Mutagen treatment of P815 tumour cells produces tum- variants that are rejected by syngeneic mice be...
Mutagen treatment of P815 tumour cells produces tum- variants that are rejected by syngeneic mice be...
Mutagen treatment of mouse P815 tumor cells produces immunogenic mutants that express new transplant...
Immunogenic tumor cell variant P35 was obtained by mutagen treatment of mouse mastocytoma P815. It e...
On the basis of the results reviewed here, there are two major mechanisms whereby tumour rejection a...
Mouse mastocytoma P815 expresses several distinct tumor rejection antigens recognized by syngeneic c...
Mouse mastocytoma P815 expresses several distinct tumor rejection antigens recognized by syngeneic c...
Tumor-associated transplantation antigens (TATA) are commonly found on rodent tumors induced by onco...
Male transmission ratio distortion (TRD) is a property of mouse t haplotypes requiring the t complex...
Transplantation experiments have demonstrated that most mouse tumors express antigens that can const...
AbstractDespite thousands of genetic polymorphisms among MHC matched mouse strains, a few unknown hi...
Minor histocompatibility (H) loci encode alloantigens that are recognized by cytotoxic T (Tc) lympho...
The P91A tumour minus (tum-) antigen is a tumour specific transplantation antigen expressed on the P...
T cells that recognize self antigen are clonally deleted in the thymus--a maturation process that oc...
Tumour development is a complex process involving susceptibility loci (oncogenes) and the accumulati...